Similar articles

• Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation.

  Ferran C, Sheehan K, Dy M, Schreiber R, Merite S, Landais P, Noel LH, Grau G, Bluestone J, Bach JF, et al. Ferran C, et al. Eur J Immunol. 1990 Mar;20(3):509-15. doi: 10.1002/eji.1830200308. Eur J Immunol. 1990. PMID: 2138557
• Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions.

  Alegre M, Depierreux M, Florquin S, Najdovski T, Vandenabeele P, Abramowicz D, Leo O, Deschodt-Lanckman M, Goldman M. Alegre M, et al. Transplant Proc. 1990 Aug;22(4):1920-1. Transplant Proc. 1990. PMID: 2143864 No abstract available.
• Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.

  Ferran C, Dy M, Sheehan K, Schreiber R, Grau G, Bluestone J, Bach JF, Chatenoud L. Ferran C, et al. Eur J Immunol. 1991 Oct;21(10):2349-53. doi: 10.1002/eji.1830211009. Eur J Immunol. 1991. PMID: 1833202
• Nakahara memorial lecture. Regulation of T lymphocyte responses: interactions among receptors.

  Fitch F, Gajewski T, Nau G, Schell S, Otten G. Fitch F, et al. Princess Takamatsu Symp. 1988;19:15-27. Princess Takamatsu Symp. 1988. PMID: 2978617 Review.
• T cell activation via cell-surface antigens other than the CD3/T cell receptor complex.

  Yokoyama WM, Shevach EM. Yokoyama WM, et al. Year Immunol. 1989;4:110-46. Year Immunol. 1989. PMID: 2467458 Review. No abstract available.